Cd6 - CD6 antigen Gene

Species: Mus musculus

Gene Type: protein coding
Gene ID: 12511

Summary

Predicted to enable several functions, including identical protein binding activity; lipopolysaccharide binding activity; and lipoteichoic acid binding activity. Predicted to be involved in several processes, including heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; lipopolysaccharide-mediated signaling pathway; and positive regulation of macromolecule metabolic process. Predicted to act upstream of or within cell adhesion. Predicted to be located in immunological synapse. Predicted to be spanning component of plasma membrane. Predicted to be part of T cell receptor complex. Predicted to be active in external side of plasma membrane. Orthologous to human CD6 (CD6 molecule). [provided by Alliance of Genome Resources, Apr 2022]

Cd6 Products (2)

mRNA Protein Name
NM_001037801.2 NP_001032890.1 T-cell differentiation antigen CD6 isoform 1 precursor
NM_009852.3 NP_033982.3 T-cell differentiation antigen CD6 isoform 2 precursor

Gene Ontology

  • Molecular Function
Molecular Function GO Annotation Evidence References Source
enables protein binding IPI
IPI: Inferred from physical interaction
9209500 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

T-cell differentiation antigen CD6

Recombinant Cd6 Proteins

Cat. No. Product Name Accession Purity
HY-P72716 CD6 Protein, Mouse (HEK293, His) Q91WN5 (L18-G396) ≥ 90%, as determined by reducing SDS-PAGE.
HY-P72923 CD6 Protein, Mouse (HEK293, Fc) Q91WN5 (G17-P243) ≥ 85%, as determined by reducing SDS-PAGE.

Related Agents

  • Clinical Phase

Clinical Phase

Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P99252 Itolizumab ≥99.0% Phase 3

Orthologs Information

Species Symbol Source ID
Homo sapiens Cd6 NCBI NCBI:923